A subgroup analysis in the women with breast cancer revealed that the mean PBMC p62 level in those with invasive carcinoma (0.30 ng/ml) was significantly lower compared to those with in-situ carcinoma (1.10 ng/ml) (p = 0.01). Here, SQSTM1 is linked to in situ carcinoma.